Changmeng Cai to Bridged Bicyclo Compounds, Heterocyclic
This is a "connection" page, showing publications Changmeng Cai has written about Bridged Bicyclo Compounds, Heterocyclic.
Connection Strength
0.061
-
Jamroze A, Liu X, Hou S, Jess Li W, Yu H, Tracz A, Jacobi J, Li Q, Nastiuk K, Chen X, Huang J, Lin K, Liu M, Cai C, Lu Y, Puzanov I, Kirk JS, Chatta G, Tang DG. Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer. Signal Transduct Target Ther. 2026 May 01; 11(1).
Score: 0.061